Bionomics company info

What does Bionomics do?
Bionomics ADR (ASX:BNO), (NASDAQ:BNOX) is a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of central nervous system disorders and diseases with high unmet medical needs. It is listed solely on the NASDAQ stock exchange under the ticker symbol BNOX. The company's operations center around advancing a pipeline of drug candidates through clinical trials, with a significant emphasis on anxiety, depression, and other related conditions. Among its key projects is BNC210, a novel, proprietary compound aimed at treating anxiety without the sedative side effects typical of current therapies. Bionomics aims to transform the treatment landscape for patients suffering from serious psychiatric and neurological conditions by developing more efficacious and safer therapeutic options.
Bionomics  company media
Company Snapshot

Is Bionomics a public or private company?

key
Ownership
Public

How many people does Bionomics employ?

people
Employees
140

What sector is Bionomics in?

pie chart
Sector
Health Care

Where is the head office for Bionomics ?

location pin
Head Office
Eastwood, Australia

What year was Bionomics founded?

founded flag
Year Founded
1996
What does Bionomics specialise in?
/Biopharmaceutical Company /Therapeutics Development /Neurological Disorders /Drug Discovery /Cancer Treatment /Clinical Trials

What are the products and/or services of Bionomics ?

Overview of Bionomics offerings
BNC210, an oral drug for treating anxiety and PTSD
BNC375, targeting Alzheimer's and cognitive defects
BNC101, focusing on colorectal cancer stem cell therapies
Collaboration in ion channel drug discovery for CNS disorders
CNS biomarker services for drug development and precision medicine
Partnerships for developing novel therapeutics in central nervous system disorders

Who is in the executive team of Bionomics ?

Bionomics leadership team
  • Dr. Spyridon  Papapetropoulos M.D., Ph.D.
    Dr. Spyridon Papapetropoulos M.D., Ph.D.
    CEO, President & Director
  • Mr. Adrian  Hinton BEC, F.C.A.
    Mr. Adrian Hinton BEC, F.C.A.
    Financial Controller
  • Mr. Timothy M. Cunningham CPA, M.B.A.
    Mr. Timothy M. Cunningham CPA, M.B.A.
    Chief Financial Officer
  • Prof. Paul  Rolan D.C.P.S.A., F.F.P.M., F.R.A.C.P., M.B.B.S., M.D.
    Prof. Paul Rolan D.C.P.S.A., F.F.P.M., F.R.A.C.P., M.B.B.S., M.D.
    Consultant Chief Medical Officer of Clinical Neuroscience
  • Dr. Julie  Kerner Ph.D.
    Dr. Julie Kerner Ph.D.
    Senior Vice President of Business Operations
  • Ms. Suzanne  Irwin B.Com., FCIS
    Ms. Suzanne Irwin B.Com., FCIS
    Company Secretary